Get started
Author

Dominique Boutriau

Efficacy profile of a bivalent S taphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study
2014 · Ali Fattom, Albert Matalon, et al. · Human Vaccines & Immunotherapeutics · 138
PDF
Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years
2008 · Lars Østergaard, Edouard Lebacq, et al. · Vaccine · 97
A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children
2009 · M. Knuf, D. Kieninger-Baum, et al. · Vaccine · 79
Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03 B adjuvant: Results of a randomized phase I trial
2015 · Jack Levy, Laurent Licini, et al. · Human Vaccines & Immunotherapeutics · 65
PDF
Immunogenicity and Safety of Three Doses of a Bivalent (B:4:P1.19,15 and B:4:P1.7-2,4) Meningococcal Outer Membrane Vesicle Vaccine in Healthy Adolescents
2007 · Dominique Boutriau, Jan Poolman, et al. · Clinical and Vaccine Immunology · 58
A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants
2007 · Terry Nolan, Stephen Lambert, et al. · Vaccine · 53
Immune response, antibody persistence, and safety of a single dose of the quadrivalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine in adolescents and adults: results of an open, randomised, controlled study
2013 · Charissa Borja-Tabora, Cecilia Montalban, et al. · BMC Infectious Diseases · 50
PDF
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers
2012 · Timo Vesikari, Aino Forstén, et al. · Human Vaccines & Immunotherapeutics · 49
Immunogenicity, Reactogenicity, and Immune Memory after Primary Vaccination with a Novel Haemophilus influenzae - Neisseria meningitidis Serogroup C Conjugate Vaccine
2007 · Heinz-J. Schmitt, Gudrun Maechler, et al. · Clinical and Vaccine Immunology · 46
Safety, Immunogenicity, and Antibody Persistence following an Investigational Streptococcus pneumoniae and Haemophilus influenzae Triple-Protein Vaccine in a Phase 1 Randomized Controlled Study in Healthy Adults
2013 · Johan Berglund, Peter Vink, et al. · Clinical and Vaccine Immunology · 38
PDF
Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus
2019 · Alessandra Ferraro, Sofia M. Buonocore, et al. · Human Vaccines & Immunotherapeutics · 36
MHC class II invariant chain–adjuvanted viral vectored vaccines enhances T cell responses in humans
2020 · Ilaria Esposito, Paola Cicconi, et al. · Science Translational Medicine · 34
A novel combined Hib-MenC-TT glycoconjugate vaccine as a booster dose for toddlers: a phase 3 open randomised controlled trial
2008 · D Pace, M Snape, et al. · Archives of Disease in Childhood · 34
A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 years
2012 · Timo Vesikari, Aino Forstén, et al. · Human Vaccines & Immunotherapeutics · 33
PDF
Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial
2015 · Charissa Fay Corazon Borja-Tabora, Cecilia Montalban, et al. · BMC Infectious Diseases · 32
PDF
Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine
2010 · Ameneh Khatami, Matthew D. Snape, et al. · The Pediatric Infectious Disease Journal · 29
Immunogenicity and Reactogenicity of Primary Immunization With a Novel Combined Haemophilus influenzae Type b and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Coadministered With a Diphtheria–Tetanus–Acellular Pertussis–Hepatitis B–Inactivated Poliovirus Vaccine at 2, 4 and 6 Months
2006 · Juan C. Tejedor, Manuel Moro, et al. · The Pediatric Infectious Disease Journal · 29
Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children
2012 · Markus Knuf, Yaela Baine, et al. · Human Vaccines & Immunotherapeutics · 28
PDF
Immunogenicity and Reactogenicity of a Booster Dose of a Novel Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine Given to Toddlers of 13–14 Months of Age With Antibody Persistence Up to 31 Months of Age
2008 · Juan C. Tejedor, Manuel Moro, et al. · The Pediatric Infectious Disease Journal · 28
Immunogenicity and Safety of H influenzae Type b–N meningitidis C/Y Conjugate Vaccine in Infants
2011 · Kristina A. Bryant, Gary S. Marshall, et al. · PEDIATRICS · 26
Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine
2010 · Terry Nolan, Peter Richmond, et al. · The Pediatric Infectious Disease Journal · 26
Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants
2009 · Colin D. Marchant, Jacqueline M. Miller, et al. · The Pediatric Infectious Disease Journal · 26
A New Combination Haemophilus influenzae Type B and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine for Primary Immunization of Infants
2007 · David Pace, Matthew Snape, et al. · The Pediatric Infectious Disease Journal · 26
Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
2009 · Pei-Lan Shao, Luan-Yin Chang, et al. · Journal of the Formosan Medical Association · 23
PDF
A Phase II, Randomized Study on an Investigational DTPw-HBV/Hib-MenAC Conjugate Vaccine Administered to Infants in Northern Ghana
2008 · Abraham Hodgson, Abudulai Adams Forgor, et al. · PLoS ONE · 22
PDF
Works count: 48
Citation count: 1,305
H-index: 23
I10-index: 35
Year
Topic
Type